QUINOLINE DERIVATIVES FOR TREATING INFLAMMATORY DISEASES Russian patent published in 2012 - IPC C07D401/04 C07D403/04 A61K31/4709 A61P29/00 C07C215/42 C07D215/18 

Abstract RU 2460727 C2

FIELD: chemistry.

SUBSTANCE: invention relates to novel quinoline derivatives of formula or pharmaceutically acceptable salts thereof, where n equals 0 or 1; when n equals 0, then R1 is hydrogen or methyl, R2 is hydroxyl, and R3 is hydrogen; and when n equals 1, R1 is hydrogen, and one of R2 and R3 is hydroxyl, and the other of R2 and R3 is hydrogen. The invention also relates to specific compounds of formula (I) and a method of producing compounds of formula (I).

EFFECT: novel quinoline derivatives are obtained, having high P2X7 antagonist activity.

9 cl, 1 tbl, 5 ex

Similar patents RU2460727C2

Title Year Author Number
MELANOCORTIN-4 RECEPTOR AGONISTS 2020
  • Kang, Seung Wan
  • Park, Hee Dong
  • Park, Hee Dong
  • Yeo, Su Jin
  • Park, Hyun Seo
  • Hong, Ji Ho
  • Ahn, Hye Won
  • Choi, Eun Sil
RU2786864C1
TLR7/8 ANTAGONISTS AND THEIR APPLICATION 2017
  • Sherer Brajan A.
  • Chen Syaolin
  • Kliri Ester
  • Brugger Nadiya
RU2758686C2
SHIP1 MODULATORS AND METHODS RELATED THERETO 2014
  • Makkenzi Llojd F.
  • Makruri Tomas B.
  • Kharvig Kertis
  • Bogutski Devid
  • Rejmond Dzheffri R.
  • Pettigryu Dzheremi D.
RU2679805C2
NEW CATECHOLAMINE-BASED PRODRUGS FOR USE IN TREATMENT OF PARKINSON'S DISEASE 2018
  • Jensen Klaus Gervig
  • Kvaerno Lisbet
  • Dzhukhl Martin
  • Jorgensen Morten
RU2806075C2
PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST P2X OF RECEPTOR AND FACTOR OF TUMOUR NECROSIS α 2004
  • Bauton-Smit Najdzhel
RU2350354C2
PRODRUG OF FLUORINE-CONTAINING AMINO ACID 2013
  • Khasikhayata Takasi
  • Otake Norikadzu
  • Miyakosi Naoki
  • Sakagami Kazunari
RU2639868C1
PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST OF P2X-RECEPTOR AND NONSTEROID ANTIINFLAMMATORY MEDICAL PRODUCT 2004
  • Bafton-Smit Najdzhel
  • Kruvis Sajmon
RU2338556C2
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS 2017
  • Li, Jialiang
  • Arista, Luca
  • Babu, Sreehari
  • Bian, Jianwei
  • Cui, Kai
  • Dillon, Michael Patrick
  • Lattmann, Rene
  • Liao, Lv
  • Lizos, Dimitrios
  • Ramos, Rita
  • Stiefl, Nikolaus Johannes
  • Ullrich, Thomas
  • Usselmann, Peggy
  • Wang, Xiaoyang
  • Waykole, Liladhar Murlidhar
  • Weiler, Sven
  • Zhang, Yubo
  • Zhou, Yizong
  • Zhu, Tingying
RU2747318C2
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS 2022
  • Li, Jialiang
  • Arista, Luca
  • Babu, Sreehari
  • Bian, Jianwei
  • Cui, Kai
  • Dillon, Michael Patrick
  • Lattmann, Rene
  • Liao, Lv
  • Lizos, Dimitrios
  • Ramos, Rita
  • Stiefl, Nikolaus Johannes
  • Ullrich, Thomas
  • Usselmann, Peggy
  • Wang, Xiaoyang
  • Waykole, Liladhar Murlidhar
  • Weiler, Sven
  • Zhang, Yubo
  • Zhou, Yizong
  • Zhu, Tingying
RU2803084C1
AMINOPYRIDINE DERIVATIVES AND APPLICATION THEREOF AS SELECTIVE ALK-2 INHIBITORS 2017
  • Li, Tszyalyan
  • Arista, Luka
  • Babu, Srikhari
  • Byan, Tszyanvej
  • Tsuj, Kaj
  • Dillon, Majkl Patrik
  • Lattmann, Rene
  • Lyao, Lv
  • Lizos, Dimitrios
  • Ramos, Rita
  • Shtifl, Nikolaus Jokhannes
  • Ullrikh, Tomas
  • Usselmann, Peggi
  • Van, Syaoyan
  • Vajkole, Liladkhar Murlidkhar
  • Vajler, Sven
  • Chzhan, Yujbo
  • Chzhou, Itszun
  • Chzhu, Tinin
RU2777979C2

RU 2 460 727 C2

Authors

Gil Sajmon Dehvid

Ehbden Mark

Dates

2012-09-10Published

2008-03-19Filed